{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T00:47:14Z","timestamp":1720140434946},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1016\/j.jpba.2012.02.022","type":"journal-article","created":{"date-parts":[[2012,3,6]],"date-time":"2012-03-06T21:01:14Z","timestamp":1331067674000},"page":"211-217","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Liquid chromatography\u2013tandem mass spectrometric assay for the light sensitive calcium channel antagonist lacidipine in human plasma"],"prefix":"10.1016","volume":"66","author":[{"given":"Vijaya Kumari","family":"Karra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nageswara Rao","family":"Pilli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Srinivasa Rao","family":"Polagani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaswanth Kumar","family":"Inamadugu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.V.L.N.","family":"Seshagiri Rao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2012.02.022_bib0005","doi-asserted-by":"crossref","first-page":"274","DOI":"10.2165\/00003495-199448020-00010","article-title":"Lacidipine: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the treatment of hypertension","volume":"48","author":"Lee","year":"1994","journal-title":"Drugs"},{"key":"10.1016\/j.jpba.2012.02.022_bib0010","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.2165\/00003495-200363210-00008","article-title":"Lacidipine: a review of its use in the management of hypertension","volume":"63","author":"McCormack","year":"2003","journal-title":"Drugs"},{"key":"10.1016\/j.jpba.2012.02.022_bib0015","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1097\/00005344-199500003-00007","article-title":"French large-scale study evaluating the tolerability and efficacy of lacidipine","volume":"25","author":"Tcherdakoff","year":"1995","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.jpba.2012.02.022_bib0020","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.vph.2010.08.003","article-title":"Lacidipine has antiatherosclerotic effects independent of its actions on lipid metabolism and blood pressure","volume":"53","author":"Anacak","year":"2010","journal-title":"Vascul. Pharmacol."},{"key":"10.1016\/j.jpba.2012.02.022_bib0025","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0302-4598(00)00073-8","article-title":"An electroanalytical investigation on the redox properties of lacidipine supporting its anti-oxidant effect","volume":"51","author":"Toniolo","year":"2000","journal-title":"Bioelectrochemistry"},{"key":"10.1016\/j.jpba.2012.02.022_bib0030","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1097\/00005344-199117040-00007","article-title":"Comparative study of lacidipine and nicidipine SR in the treatment of hypertension: an Italian multicenter study","volume":"17","author":"Leonetti","year":"1991","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.jpba.2012.02.022_bib0035","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/00005344-199117041-00002","article-title":"Pharmacology of lacidipine, a vascular-selective calcium antagonist","volume":"17","author":"Dino","year":"1991","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.jpba.2012.02.022_bib0040","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.talanta.2005.04.028","article-title":"Development of a liquid\u2013liquid extraction procedure for five 1,4-dihydropyridines calcium channel antagonists from human plasma using experimental design","volume":"67","author":"Baranda","year":"2005","journal-title":"Talanta"},{"key":"10.1016\/j.jpba.2012.02.022_bib0045","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0021-9673(99)01070-5","article-title":"High-performance liquid chromatography with amperometric detection applied to the screening of 1,4-dihydropyridines in human plasma","volume":"870","author":"Lopez","year":"2000","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jpba.2012.02.022_bib0050","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0378-4347(92)80481-5","article-title":"Validation of a high-performance liquid chromatographic-radioimmunoassay method for the determination of lacidipine in plasma","volume":"573","author":"Pellegatti","year":"1992","journal-title":"J. Chromatogr. Biomed. Appl."},{"key":"10.1016\/j.jpba.2012.02.022_bib0055","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S0731-7085(01)00584-2","article-title":"Determination of lacidipine from urine by HPTLC using off-line SPE","volume":"28","author":"Kharat","year":"2002","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2012.02.022_bib0060","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0021-9673(93)83335-P","article-title":"Investigation into lacidipine and related metabolites by high-performance liquid chromatography\u2013mass spectrometry","volume":"647","author":"Rossato","year":"1993","journal-title":"J. Chromatogr."},{"key":"10.1016\/j.jpba.2012.02.022_bib0065","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1002\/jms.664","article-title":"Simple, sensitive and rapid liquid chromatographic\/electrospray ionization tandem mass spectrometric method for the quantification of lacidipine in human plasma","volume":"39","author":"Ramakrishna","year":"2004","journal-title":"J. Mass Spectrom."},{"key":"10.1016\/j.jpba.2012.02.022_bib0070","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.jpba.2008.04.018","article-title":"Ultra-performance liquid chromatography\u2013tandem mass spectrometry for the determination of lacidipine in human plasma and its application in a pharmacokinetic study","volume":"47","author":"Tang","year":"2008","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2012.02.022_bib0075","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0731-7085(01)00505-2","article-title":"Photodegradation studies on lacidipine in solution: basic experiments with a cis\u2013trans reversible photoequilibrium under UV-A radiation exposure","volume":"27","author":"De","year":"2002","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2012.02.022_bib0080","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.forsciint.2004.11.014","article-title":"Instability of calcium channel antagonists during sample preparation for LC\u2013MS\u2013MS analysis of serum samples","volume":"156","author":"Baranda","year":"2006","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.jpba.2012.02.022_bib0085","unstructured":"Food and Drug Administration, Guidance for Industry, Bioanalytical Method Validation, 2001."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708512001161?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708512001161?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,25]],"date-time":"2018-11-25T13:22:22Z","timestamp":1543152142000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708512001161"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":17,"alternative-id":["S0731708512001161"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2012.02.022","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7]]}}}